Current uses of isolated limb perfusion in the clinic and a model system for new strategies.
about
Guidelines for the management of soft tissue sarcomasThe impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion modelUK guidelines for the management of soft tissue sarcomasTranslational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogsGene therapy progress and prospects: electroporation and other physical methods.One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases.Histamine combined with melphalan in isolated limb perfusion for the treatment of locally advanced soft tissue sarcomas: preclinical studies in rats.Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery.Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosisThe pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelA multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.Emerging treatments for soft tissue sarcoma of adults.Intratumoral immunotherapy: using the tumour against itself.Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?Interleukin-10 and the immune response against cancer: a counterpoint.On the TRAIL of a new therapy for leukemia.TNF-alpha levels in cancer patients relate to social variablesHigh-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liverEffectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.Surgery and radiotherapy in the treatment of cutaneous melanomaTNF-alpha downregulates E-cadherin and sensitizes response to γ-irradiation in Caco-2 cells.Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?Pharmacotherapy of regional melanoma therapy.Regional treatment strategies for in-transit melanoma metastasis.HLA-G regulators in cancer medicine: an outline of key requirements.Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature.Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer.Synergy between enzastaurin doxorubicin in inducing melanoma apoptosis.Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.TNF-α expression in the UCB-MSCs as stable source inhibits gastric cancers growth in nude mice.Immunostimulatory and cytotoxic activities of Indigofera suffruticosa (Fabaceae).Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.
P2860
Q21296866-0A76DA72-E754-4D2A-B316-151EAFEF0335Q24805237-7C7E88CB-A6EE-403D-B8C5-0CBA9891FA4DQ28076730-2F738B73-6C89-4692-BBBC-B47CC128FDAEQ30891500-B260F94B-31D4-4D9B-995F-F074E7C06029Q31104973-63DA558A-5A4C-4E74-88D0-B368F23D906DQ33209414-C34D4AC0-0134-4B04-BDB0-E2C2E937C381Q33224018-97446D1C-7544-4020-87DE-8C66E7F4EEC8Q33245795-434E71F0-EFFB-4AE8-BAE6-F46512A1BA0BQ33263624-DD66637B-F507-4305-A43C-A7148F3BEB1BQ33325343-5C207952-997F-45C0-88A6-6D66ACD1604FQ33955599-BD718B5D-7E10-4458-BAA8-FC0DA8968EF8Q34054797-C195C7D3-C0EE-4596-8A38-AB6F59A69485Q34241776-9FA3A8B2-B71F-4048-BD39-A5745C98D40FQ34655297-7ED5C657-01EE-4312-8F08-86FD2689F5C1Q35847459-CAF13718-3209-4AA3-BB84-10E5D3122EE0Q35891767-452E3A58-AC6E-448F-B830-8A7586B3FB79Q35967402-AE1DC422-A612-4EA7-811A-7633D1D81B73Q35988030-D248B253-8853-4408-8DC5-3322B3216A21Q36230845-7FBA2F4D-9671-4199-A51F-105D63990716Q36276594-99C25A6E-5B42-40F0-8768-7F6DA2FDE8D0Q36285964-A7B11EB1-D06A-4AE6-8A07-2E31E9ABBEA1Q36319346-52827407-14FA-43E8-B40C-A72028E4354FQ36497626-8EE3BEE8-AFCB-4F52-805E-3F8B41498756Q36520700-9C240892-0C59-49A9-976A-E7E88EC60204Q37130237-8CF75840-C9F1-45E3-B084-B1836D5CFEC4Q37266677-83B3E8CD-5A7E-4870-8E01-A6B1B174ACAAQ37376902-C33EFB58-31B4-4CE8-9966-53691CF9F22AQ37513298-4D0D08A5-53B3-4454-A0C7-EFA880750E9FQ37650312-ADB7576B-D44E-4919-A05C-1074A7837A78Q37812815-EE9E55BC-1E0E-46C9-BC89-87AAE066659DQ37906387-10D77F00-C3E6-4B0F-AB68-817526D95956Q38073582-666833BC-DDAC-4099-B684-A64E55294CFDQ38112578-954BEC9E-E4BE-4146-AE48-852421E53905Q38120535-6DF581E8-CC3F-4102-9518-61D39468EC2EQ38166249-6C7484AF-63AE-4268-A71A-128D5314ACD0Q39124162-22D0CEEC-57AD-4A5E-8B71-07E2A021CC91Q39251874-8CFF51B5-37AC-4C3F-A33F-19F9A1F21660Q39358246-9498A0B3-2E54-4FE6-A509-1C63F4A99A11Q39528021-88833B28-0BBE-4342-82F1-62A2B69EC243Q39570683-A7A0C8A0-F1F3-437F-B44D-BA4D77170394
P2860
Current uses of isolated limb perfusion in the clinic and a model system for new strategies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Current uses of isolated limb ...... del system for new strategies.
@ast
Current uses of isolated limb ...... del system for new strategies.
@en
type
label
Current uses of isolated limb ...... del system for new strategies.
@ast
Current uses of isolated limb ...... del system for new strategies.
@en
prefLabel
Current uses of isolated limb ...... del system for new strategies.
@ast
Current uses of isolated limb ...... del system for new strategies.
@en
P2093
P1433
P1476
Current uses of isolated limb ...... del system for new strategies.
@en
P2093
Alexander M M Eggermont
Johannes H W de Wilt
Timo L M ten Hagen
P304
P356
10.1016/S1470-2045(03)01141-0
P577
2003-07-01T00:00:00Z